Veterinary Medicines

Xylazine GNRC 20 mg/ml oplossing voor injectie voor runderen, paarden, honden en katten

Authorised
  • Xylazine
Download as PDF

Product identification

Medicine name:
Xylazine GNRC 20 mg/ml oplossing voor injectie voor runderen, paarden, honden en katten
Active substance:
  • Xylazine
Target species:
  • Cattle
  • Horse
  • Cat
  • Dog
Route of administration:
  • Intravenous use
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Xylazine
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        1
        day
    • Horse
      • Meat and offal
        1
        day
  • Subcutaneous use
    • Cat
  • Intramuscular use
    • Cattle
      • Meat and offal
        1
        day
    • Cat
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN05CM92
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan Nederland B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 131451
Date of authorisation status change:
This information is not available for this product.

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 7/03/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."